Stocksigma LogoStocksigma Logo

Kilitch Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results

Kilitch Drugs (India) Limited will hold its Board of Directors meeting on 6th Nov'26 to consider and approve unaudited standalone and consolidated

Kilitch Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results

Kilitch Drugs India Ltd 路 Intimation 路 06 Nov 2026, 5:30 am

Kilitch Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results Kilitch Drugs (India) Limited will hold its Board of Directors meeting on 6th Nov'26 to consider and approve unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours post the formal dissemination of the financial results to stock exchanges.

Original exchange filing (PDF)

More announcements from Kilitch Drugs India Ltd

All Kilitch Drugs India Ltd announcements